Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas (COPSDAVF) (COPSDAVF)
Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas
Sponsor: Beijing Haidian Hospital
Listed as NCT03192800, this observational or N/A phase trial focuses on Spinal Vascular Disorder Nos and remains ongoing. Sponsored by Beijing Haidian Hospital, it has been updated 10 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
May 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2021 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2021 — May 2021 [monthly]
Unknown Status
▶ Show 5 earlier versions
-
May 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — May 2020 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Jul 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Haidian Hospital
- Hongqi Zhang, MD
For direct contact, visit the study record on ClinicalTrials.gov .